Global Dermatology Drugs Market Growth 2020-2025

November 2020 | 166 pages | ID: G6938F16CA4CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, over the next five years the Dermatology Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dermatology Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Dermatology Drugs, covering the supply chain analysis, impact assessment to the Dermatology Drugs market size growth rate in several scenarios, and the measures to be undertaken by Dermatology Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

• External Use
• Oral
• Injection

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

• Psoriasis
• Skin Infections
• Acne
• Dermatitis
• Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• AbbVie
• LEO Pharma
• Johnson & Johnson
• Galderma
• Bristol-Myers Squibb
• Bayer
• Merz Pharma
• Novartis
• Bausch Health Companies Inc
• Pfizer
• GlaxoSmithKline

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Dermatology Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Dermatology Drugs market by identifying its various subsegments.
• Focuses on the key global Dermatology Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Dermatology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Dermatology Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dermatology Drugs Consumption 2015-2025
  2.1.2 Dermatology Drugs Consumption CAGR by Region
2.2 Dermatology Drugs Segment by Type
  2.2.1 External Use
  2.2.2 Oral
  2.2.3 Injection
2.3 Dermatology Drugs Consumption by Type
  2.3.1 Global Dermatology Drugs Consumption Market Share by Type (2015-2020)
  2.3.2 Global Dermatology Drugs Revenue and Market Share by Type (2015-2020)
  2.3.3 Global Dermatology Drugs Sale Price by Type (2015-2020)
2.4 Dermatology Drugs Segment by Application
  2.4.1 Psoriasis
  2.4.2 Skin Infections
  2.4.3 Acne
  2.4.4 Dermatitis
  2.4.5 Other
2.5 Dermatology Drugs Consumption by Application
  2.5.1 Global Dermatology Drugs Consumption Market Share by Type (2015-2020)
  2.5.2 Global Dermatology Drugs Value and Market Share by Type (2015-2020)
  2.5.3 Global Dermatology Drugs Sale Price by Type (2015-2020)

3 GLOBAL DERMATOLOGY DRUGS BY COMPANY

3.1 Global Dermatology Drugs Sales Market Share by Company
  3.1.1 Global Dermatology Drugs Sales by Company (2018-2020)
  3.1.2 Global Dermatology Drugs Sales Market Share by Company (2018-2020)
3.2 Global Dermatology Drugs Revenue Market Share by Company
  3.2.1 Global Dermatology Drugs Revenue by Company (2018-2020)
  3.2.2 Global Dermatology Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Dermatology Drugs Sale Price by Company
3.4 Global Dermatology Drugs Manufacturing Base Distribution, Sales Area, Type by Company
  3.4.1 Global Dermatology Drugs Manufacturing Base Distribution and Sales Area by Company
  3.4.2 Players Dermatology Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 DERMATOLOGY DRUGS BY REGIONS

4.1 Dermatology Drugs by Regions
4.2 Americas Dermatology Drugs Consumption Growth
4.3 APAC Dermatology Drugs Consumption Growth
4.4 Europe Dermatology Drugs Consumption Growth
4.5 Middle East & Africa Dermatology Drugs Consumption Growth

5 AMERICAS

5.1 Americas Dermatology Drugs Consumption by Countries
  5.1.1 Americas Dermatology Drugs Consumption by Countries (2015-2020)
  5.1.2 Americas Dermatology Drugs Value by Countries (2015-2020)
5.2 Americas Dermatology Drugs Consumption by Type
5.3 Americas Dermatology Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Dermatology Drugs Consumption by Regions
  6.1.1 APAC Dermatology Drugs Consumption by Regions (2015-2020)
  6.1.2 APAC Dermatology Drugs Value by Regions (2015-2020)
6.2 APAC Dermatology Drugs Consumption by Type
6.3 APAC Dermatology Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 EUROPE

7.1 Europe Dermatology Drugs by Countries
  7.1.1 Europe Dermatology Drugs Consumption by Countries (2015-2020)
  7.1.2 Europe Dermatology Drugs Value by Countries (2015-2020)
7.2 Europe Dermatology Drugs Consumption by Type
7.3 Europe Dermatology Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dermatology Drugs by Countries
  8.1.1 Middle East & Africa Dermatology Drugs Consumption by Countries (2015-2020)
  8.1.2 Middle East & Africa Dermatology Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Dermatology Drugs Consumption by Type
8.3 Middle East & Africa Dermatology Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels
10.2 Dermatology Drugs Distributors
10.3 Dermatology Drugs Customer

11 GLOBAL DERMATOLOGY DRUGS MARKET FORECAST

11.1 Global Dermatology Drugs Consumption Forecast (2021-2025)
11.2 Global Dermatology Drugs Forecast by Regions
  11.2.1 Global Dermatology Drugs Forecast by Regions (2021-2025)
  11.2.2 Global Dermatology Drugs Value Forecast by Regions (2021-2025)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Dermatology Drugs Forecast by Type
11.8 Global Dermatology Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 AbbVie
  12.1.1 Company Information
  12.1.2 Dermatology Drugs Product Offered
  12.1.3 AbbVie Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.1.4 Main Business Overview
  12.1.5 AbbVie Latest Developments
12.2 LEO Pharma
  12.2.1 Company Information
  12.2.2 Dermatology Drugs Product Offered
  12.2.3 LEO Pharma Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.2.4 Main Business Overview
  12.2.5 LEO Pharma Latest Developments
12.3 Johnson & Johnson
  12.3.1 Company Information
  12.3.2 Dermatology Drugs Product Offered
  12.3.3 Johnson & Johnson Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.3.4 Main Business Overview
  12.3.5 Johnson & Johnson Latest Developments
12.4 Galderma
  12.4.1 Company Information
  12.4.2 Dermatology Drugs Product Offered
  12.4.3 Galderma Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.4.4 Main Business Overview
  12.4.5 Galderma Latest Developments
12.5 Bristol-Myers Squibb
  12.5.1 Company Information
  12.5.2 Dermatology Drugs Product Offered
  12.5.3 Bristol-Myers Squibb Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.5.4 Main Business Overview
  12.5.5 Bristol-Myers Squibb Latest Developments
12.6 Bayer
  12.6.1 Company Information
  12.6.2 Dermatology Drugs Product Offered
  12.6.3 Bayer Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.6.4 Main Business Overview
  12.6.5 Bayer Latest Developments
12.7 Merz Pharma
  12.7.1 Company Information
  12.7.2 Dermatology Drugs Product Offered
  12.7.3 Merz Pharma Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.7.4 Main Business Overview
  12.7.5 Merz Pharma Latest Developments
12.8 Novartis
  12.8.1 Company Information
  12.8.2 Dermatology Drugs Product Offered
  12.8.3 Novartis Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.8.4 Main Business Overview
  12.8.5 Novartis Latest Developments
12.9 Bausch Health Companies Inc
  12.9.1 Company Information
  12.9.2 Dermatology Drugs Product Offered
  12.9.3 Bausch Health Companies Inc Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.9.4 Main Business Overview
  12.9.5 Bausch Health Companies Inc Latest Developments
12.10 Pfizer
  12.10.1 Company Information
  12.10.2 Dermatology Drugs Product Offered
  12.10.3 Pfizer Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.10.4 Main Business Overview
  12.10.5 Pfizer Latest Developments
12.11 GlaxoSmithKline
  12.11.1 Company Information
  12.11.2 Dermatology Drugs Product Offered
  12.11.3 GlaxoSmithKline Dermatology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.11.4 Main Business Overview
  12.11.5 GlaxoSmithKline Latest Developments

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Research Methodology
Table 2. Data Source
Table 3. Dermatology Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of External Use
Table 5. Major Players of Oral
Table 6. Major Players of Injection
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Dermatology Drugs Consumption Market Share by Type (2015-2020)
Table 9. Global Dermatology Drugs Revenue by Type (2015-2020) ($ million)
Table 10. Global Dermatology Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Dermatology Drugs Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Dermatology Drugs Consumption Market Share by Application (2015-2020)
Table 14. Global Dermatology Drugs Value by Application (2015-2020)
Table 15. Global Dermatology Drugs Value Market Share by Application (2015-2020)
Table 16. Global Dermatology Drugs Sale Price by Application (2015-2020)
Table 17. Global Dermatology Drugs Sales by Company (2017-2019) (K Units)
Table 18. Global Dermatology Drugs Sales Market Share by Company (2017-2019)
Table 19. Global Dermatology Drugs Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Dermatology Drugs Revenue Market Share by Company (2017-2019)
Table 21. Global Dermatology Drugs Sale Price by Company (2017-2019)
Table 22. Global Dermatology Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Dermatology Drugs Products Offered
Table 24. Dermatology Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Dermatology Drugs Consumption by Regions 2015-2020 (K Units)
Table 26. Global Dermatology Drugs Consumption Market Share by Regions 2015-2020
Table 27. Global Dermatology Drugs Value by Regions 2015-2020 ($ Millions)
Table 28. Global Dermatology Drugs Value Market Share by Regions 2015-2020
Table 29. Americas Dermatology Drugs Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Dermatology Drugs Consumption Market Share by Countries (2015-2020)
Table 31. Americas Dermatology Drugs Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Dermatology Drugs Value Market Share by Countries (2015-2020)
Table 33. Americas Dermatology Drugs Consumption by Type (2015-2020) (K Units)
Table 34. Americas Dermatology Drugs Consumption Market Share by Type (2015-2020)
Table 35. Americas Dermatology Drugs Consumption by Application (2015-2020) (K Units)
Table 36. Americas Dermatology Drugs Consumption Market Share by Application (2015-2020)
Table 37. APAC Dermatology Drugs Consumption by Regions (2015-2020) (K Units)
Table 38. APAC Dermatology Drugs Consumption Market Share by Regions (2015-2020)
Table 39. APAC Dermatology Drugs Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Dermatology Drugs Value Market Share by Regions (2015-2020)
Table 41. APAC Dermatology Drugs Consumption by Type (2015-2020) (K Units)
Table 42. APAC Dermatology Drugs Consumption Market Share by Type (2015-2020)
Table 43. APAC Dermatology Drugs Consumption by Application (2015-2020) (K Units)
Table 44. APAC Dermatology Drugs Consumption Market Share by Application (2015-2020)
Table 45. Europe Dermatology Drugs Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Dermatology Drugs Consumption Market Share by Countries (2015-2020)
Table 47. Europe Dermatology Drugs Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Dermatology Drugs Value Market Share by Countries (2015-2020)
Table 49. Europe Dermatology Drugs Consumption by Type (2015-2020) (K Units)
Table 50. Europe Dermatology Drugs Consumption Market Share by Type (2015-2020)
Table 51. Europe Dermatology Drugs Consumption by Application (2015-2020) (K Units)
Table 52. Europe Dermatology Drugs Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Dermatology Drugs Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Dermatology Drugs Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Dermatology Drugs Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Dermatology Drugs Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Dermatology Drugs Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Dermatology Drugs Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Dermatology Drugs Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Dermatology Drugs Consumption Market Share by Application (2015-2020)
Table 61. Dermatology Drugs Distributors List
Table 62. Dermatology Drugs Customer List
Table 63. Global Dermatology Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Dermatology Drugs Consumption Market Forecast by Regions
Table 65. Global Dermatology Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Dermatology Drugs Value Market Share Forecast by Regions
Table 67. Global Dermatology Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Dermatology Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Dermatology Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Dermatology Drugs Value Market Share Forecast by Type (2021-2025)
Table 71. Global Dermatology Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Dermatology Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Dermatology Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Dermatology Drugs Value Market Share Forecast by Application (2021-2025)
Table 75. AbbVie Product Offered
Table 76. AbbVie Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. AbbVie Main Business
Table 78. AbbVie Latest Developments
Table 79. AbbVie Basic Information, Company Total Revenue (in $ million), Dermatology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. LEO Pharma Product Offered
Table 81. LEO Pharma Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. LEO Pharma Main Business
Table 83. LEO Pharma Latest Developments
Table 84. LEO Pharma Basic Information, Company Total Revenue (in $ million), Dermatology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Johnson & Johnson Product Offered
Table 86. Johnson & Johnson Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Johnson & Johnson Main Business
Table 88. Johnson & Johnson Latest Developments
Table 89. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Dermatology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Galderma Product Offered
Table 91. Galderma Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Galderma Main Business
Table 93. Galderma Latest Developments
Table 94. Galderma Basic Information, Company Total Revenue (in $ million), Dermatology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Bristol-Myers Squibb Product Offered
Table 96. Bristol-Myers Squibb Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Bristol-Myers Squibb Main Business
Table 98. Bristol-Myers Squibb Latest Developments
Table 99. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Dermatology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Bayer Product Offered
Table 101. Bayer Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Bayer Main Business
Table 103. Bayer Latest Developments
Table 104. Bayer Basic Information, Company Total Revenue (in $ million), Dermatology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Merz Pharma Product Offered
Table 106. Merz Pharma Basic Information, Company Total Revenue (in $ million), Dermatology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Merz Pharma Main Business
Table 108. Merz Pharma Latest Developments
Table 109. Merz Pharma Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. Novartis Product Offered
Table 111. Novartis Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Novartis Main Business
Table 113. Novartis Latest Developments
Table 114. Novartis Basic Information, Company Total Revenue (in $ million), Dermatology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Bausch Health Companies Inc Product Offered
Table 116. Bausch Health Companies Inc Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Bausch Health Companies Inc Main Business
Table 118. Bausch Health Companies Inc Latest Developments
Table 119. Bausch Health Companies Inc Basic Information, Company Total Revenue (in $ million), Dermatology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Product Offered
Table 121. Pfizer Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Pfizer Basic Information, Company Total Revenue (in $ million), Dermatology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. GlaxoSmithKline Product Offered
Table 126. GlaxoSmithKline Dermatology Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. GlaxoSmithKline Main Business
Table 128. GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. GlaxoSmithKline Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Dermatology Drugs
Figure 2. Dermatology Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Dermatology Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Dermatology Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of External Use
Figure 7. Product Picture of Oral
Figure 8. Product Picture of Injection
Figure 9. Global Dermatology Drugs Consumption Market Share by Type (2015-2020)
Figure 10. Global Dermatology Drugs Value Market Share by Type (2015-2020)
Figure 11. Dermatology Drugs Consumed in Psoriasis
Figure 12. Global Dermatology Drugs Market: Psoriasis (2015-2020) (K Units)
Figure 13. Global Dermatology Drugs Market: Psoriasis (2015-2020) ($ Millions)
Figure 14. Dermatology Drugs Consumed in Skin Infections
Figure 15. Global Dermatology Drugs Market: Skin Infections (2015-2020) (K Units)
Figure 16. Global Dermatology Drugs Market: Skin Infections (2015-2020) ($ Millions)
Figure 17. Dermatology Drugs Consumed in Acne
Figure 18. Global Dermatology Drugs Market: Acne (2015-2020) (K Units)
Figure 19. Global Dermatology Drugs Market: Acne (2015-2020) ($ Millions)
Figure 20. Dermatology Drugs Consumed in Dermatitis
Figure 21. Global Dermatology Drugs Market: Dermatitis (2015-2020) (K Units)
Figure 22. Global Dermatology Drugs Market: Dermatitis (2015-2020) ($ Millions)
Figure 23. Dermatology Drugs Consumed in Other
Figure 24. Global Dermatology Drugs Market: Other (2015-2020) (K Units)
Figure 25. Global Dermatology Drugs Market: Other (2015-2020) ($ Millions)
Figure 26. Global Dermatology Drugs Consumption Market Share by Application (2015-2020)
Figure 27. Global Dermatology Drugs Value Market Share by Application (2015-2020)
Figure 28. Global Dermatology Drugs Sales Market Share by Company in 2017
Figure 29. Global Dermatology Drugs Sales Market Share by Company in 2019
Figure 30. Global Dermatology Drugs Revenue Market Share by Company in 2017
Figure 31. Global Dermatology Drugs Revenue Market Share by Company in 2019
Figure 32. Global Dermatology Drugs Sale Price by Company in 2019
Figure 33. Global Dermatology Drugs Consumption Market Share by Regions 2015-2020
Figure 34. Global Dermatology Drugs Value Market Share by Regions 2015-2020
Figure 35. Americas Dermatology Drugs Consumption 2015-2020 (K Units)
Figure 36. Americas Dermatology Drugs Value 2015-2020 ($ Millions)
Figure 37. APAC Dermatology Drugs Consumption 2015-2020 (K Units)
Figure 38. APAC Dermatology Drugs Value 2015-2020 ($ Millions)
Figure 39. Europe Dermatology Drugs Consumption 2015-2020 (K Units)
Figure 40. Europe Dermatology Drugs Value 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Dermatology Drugs Consumption 2015-2020 (K Units)
Figure 42. Middle East & Africa Dermatology Drugs Value 2015-2020 ($ Millions)
Figure 43. Americas Dermatology Drugs Consumption Market Share by Countries in 2019
Figure 44. Americas Dermatology Drugs Value Market Share by Countries in 2019
Figure 45. Americas Dermatology Drugs Consumption Market Share by Type in 2019
Figure 46. Americas Dermatology Drugs Consumption Market Share by Application in 2019
Figure 47. United States Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 48. United States Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 49. Canada Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 50. Canada Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 51. Mexico Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 52. Mexico Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 53. APAC Dermatology Drugs Consumption Market Share by Countries in 2019
Figure 54. APAC Dermatology Drugs Value Market Share by Regions in 2019
Figure 55. APAC Dermatology Drugs Consumption Market Share by Type in 2019
Figure 56. APAC Dermatology Drugs Consumption Market Share by Application in 2019
Figure 57. China Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 58. China Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 59. Japan Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 60. Japan Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 61. Korea Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 62. Korea Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 63. Southeast Asia Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 64. Southeast Asia Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 65. India Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 66. India Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 67. Australia Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 68. Australia Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 69. Europe Dermatology Drugs Consumption Market Share by Countries in 2019
Figure 70. Europe Dermatology Drugs Value Market Share by Countries in 2019
Figure 71. Europe Dermatology Drugs Consumption Market Share by Type in 2019
Figure 72. Europe Dermatology Drugs Consumption Market Share by Application in 2019
Figure 73. Germany Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 74. Germany Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 75. France Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 76. France Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 77. UK Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 78. UK Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 79. Italy Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 80. Italy Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 81. Russia Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 82. Russia Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 83. Middle East & Africa Dermatology Drugs Consumption Market Share by Countries in 2019
Figure 84. Middle East & Africa Dermatology Drugs Value Market Share by Countries in 2019
Figure 85. Middle East & Africa Dermatology Drugs Consumption Market Share by Type in 2019
Figure 86. Middle East & Africa Dermatology Drugs Consumption Market Share by Application in 2019
Figure 87. Egypt Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 88. Egypt Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 89. South Africa Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 90. South Africa Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 91. Israel Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 92. Israel Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 93. Turkey Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 94. Turkey Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 95. GCC Countries Dermatology Drugs Consumption Growth 2015-2020 (K Units)
Figure 96. GCC Countries Dermatology Drugs Value Growth 2015-2020 ($ Millions)
Figure 97. Global Dermatology Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 98. Global Dermatology Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 99. Americas Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 100. Americas Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 101. APAC Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 102. APAC Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 103. Europe Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 104. Europe Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 105. Middle East & Africa Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 106. Middle East & Africa Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 107. United States Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 108. United States Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 109. Canada Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 110. Canada Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 111. Mexico Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 112. Mexico Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 113. Brazil Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 114. Brazil Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 115. China Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 116. China Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 117. Japan Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 118. Japan Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 119. Korea Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 120. Korea Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 121. Southeast Asia Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 122. Southeast Asia Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 123. India Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 124. India Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 125. Australia Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 126. Australia Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 127. Germany Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 128. Germany Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 129. France Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 130. France Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 131. UK Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 132. UK Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 133. Italy Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 134. Italy Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 135. Russia Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 136. Russia Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 137. Spain Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 138. Spain Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 139. Egypt Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 140. Egypt Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 141. South Africa Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 142. South Africa Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 143. Israel Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 144. Israel Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 145. Turkey Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 146. Turkey Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 147. GCC Countries Dermatology Drugs Consumption 2021-2025 (K Units)
Figure 148. GCC Countries Dermatology Drugs Value 2021-2025 ($ Millions)
Figure 149. AbbVie Dermatology Drugs Market Share (2018-2020)
Figure 150. LEO Pharma Dermatology Drugs Market Share (2018-2020)
Figure 151. Johnson & Johnson Dermatology Drugs Market Share (2018-2020)
Figure 152. Galderma Dermatology Drugs Market Share (2018-2020)
Figure 153. Bristol-Myers Squibb Dermatology Drugs Market Share (2018-2020)
Figure 154. Bayer Dermatology Drugs Market Share (2018-2020)
Figure 155. Merz Pharma Dermatology Drugs Market Share (2018-2020)
Figure 156. Novartis Dermatology Drugs Market Share (2018-2020)
Figure 157. Bausch Health Companies Inc Dermatology Drugs Market Share (2018-2020)
Figure 158. Pfizer Dermatology Drugs Market Share (2018-2020)
Figure 159. GlaxoSmithKline Dermatology Drugs Market Share (2018-2020)